Financial Performance - Q1 FY27 vs Q1 FY26

  • Revenue from Operations: ₹450.2 crore (vs ₹386.1 crore), growth of 16.6% YoY
  • Total Cost: ₹337.0 crore (vs ₹296.9 crore)
  • EBITDA: ₹113.2 crore (vs ₹89.1 crore), growth of 27.1% YoY
  • EBITDA Margin: 25.2% (vs 23.1%), expansion of 210 basis points
  • Depreciation: ₹32.4 crore (vs ₹30.8 crore)
  • Other Income: ₹5.1 crore (vs ₹7.5 crore)
  • EBIT: ₹86.0 crore (vs ₹65.8 crore), growth of 30.6% YoY
  • Finance Cost: ₹8.3 crore (vs ₹4.6 crore)
  • Profit Before Tax: ₹77.7 crore (vs ₹61.2 crore), growth of 26.9% YoY
  • Current Tax: ₹20.8 crore (vs ₹16.0 crore)
  • Profit After Tax (PAT): ₹56.9 crore
  • PAT Margin: 12.6% (vs 11.7%), expansion of 90 basis points

Operational Highlights

  • 12% CAGR revenue growth over the last 7 years
  • Double-digit patient and test volume growth
  • 17% growth in specialty testing revenues
  • B2C revenue up 18% YoY, contributing 57% of total revenue
  • B2B revenue up 15% YoY, contributing 43% of total revenue
  • Added 295 service points in Q1 FY27 with rationalization of 318 non-productive centres
  • Centre-to-Lab Ratio improved to 24:1 from 21:1 LY
  • Network includes 209 Clinical Labs, 35 ISO:15189 Accredited Labs (31 India / 4 Kenya), and 2 CAP Accredited Labs in India
  • Over 45 years of experience, 4,500+ tests & profiles, 5,000+ service network

Geographic Revenue Distribution

  • North India contribution: 18% of domestic revenue (up from 17%)
  • Approximately 750 service points across India

Strategic Initiatives - Metropolis 3.0

Leading with Technology: AI and digital innovation including Second-generation Point of Sale platform, Partner Portal, Customer Data Platform, Sales CRM with enterprise-grade security

Differentiate Scientifically:

  • 36 new tests added in Q1FY27 (including CDP)
  • 347 tests added in FY26 including integrating Core menu
  • 99% EQAS external quality assurance score
  • 99.99% report accuracy
  • 100% labs under CAP/NABL/KENAS or benchmarked
  • NGS/molecular genomics growth with AI-enabled genetic reporting
  • Centres of Excellence: Women & Child Health and Oncology
  • Medical Advisory Board with 60+ subject-matter experts

Consistent, Profitable Growth: Focus on operating leverage, automation, and process efficiencies

Brand Promise: Building trust through precise, compassionate care and ethical practices

TruHealth Performance

  • Revenue growth: 22%
  • Contribution: 18%
  • Radiology integrated wellness packages grew 40%+
  • Premium TruHealth packages grew 50%+
  • Launched AI-enabled personalized nutrition and TruHealth Mind & Body for cognitive wellness
  • Introduced dedicated Wellness Zones at marquee centres

ESG Goals & Initiatives

Environmental: Carbon neutrality by 2043, 45% lower emissions intensity & 50% less plastic by 2030, zero waste & water neutrality by 2043

Social: B2C NPS @ 90 by 2028, 100% OHS awareness & training, gender-neutral workforce by 2028, 6 lakh direct beneficiaries by 2043

Governance: Zero data breaches, patient-data protection under ISO 27001 & ISO 27701, zero instances of non-compliance

CSR Initiatives

Adolescent Reproductive Sexual Health (ARSH):

  • 1.3 lakh+ adolescents reached
  • 6,300+ Kishori Manch groups and 2,900+ Girl Champions
  • 8,120+ girls counselled and 2,030+ healthcare referrals
  • 2.9 lakh+ organic app downloads through Too Shy To Ask platform

MedEngage:

  • 320+ scholarships awarded
  • 89+ research grants supported
  • Presence across 44 aspirational districts
  • MedTalks and webinars reaching over 1 lakh views

Preventive Healthcare:

  • 40,000+ preventive health screenings conducted
  • 520 TB patients supported with nutritional assistance
  • 100% treatment adherence among supported TB patients
  • 88% beneficiaries showed improvement in BMI/weight

Leadership Team

  • Ameera Shah: Promoter & Executive Chairperson
  • Surendran Chemmenkotil: Managing Director
  • Sameer Patel: Chief Financial Officer
  • Avadhut Joshi: Chief Business Development Officer
  • Diya Suri: Chief People Officer
  • Dr. Kirti Kazi: Chief Scientific & Innovation Officer
  • Mohan Menon: Chief Marketing Officer
  • Bhoopendra Rajawat: Chief Business Officer West and East
  • Kannan Alangadan: Chief Business Officer South
  • Pinakin Shah: Chief Information Officer
  • Glen Menezes: Group Head – Customer Success
  • Umesh Rai: Head - Emerging Business
  • Ravikumar Kartha: Group Head - Internal Assurance and Business Excellence
  • Dr. Monika Prabhakar: Group Head - Lab Operations

Recent Awards & Recognition (2025-2026)

  • Best Healthcare Brands Award, ET Edge (2026)
  • Excellence in Laboratory Quality Award - BW HealthcareWorld (May'26)
  • Ameera Shah - Most Powerful Woman in Business by Fortune India (2025)
  • Most Innovative Organizations Award by ET Now (2025)
  • Hurun India Family Business Excellence Award (2025)
  • Various other healthcare leadership awards

Market Context

  • India diagnostic labs market size: ~US$11 bn (2025)
  • Projected CAGR: ~11% (2025–2034E)
  • Organised chains' share: ~15%
  • >60% share of mortality from non-communicable diseases